Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2014

Dec 31, 2014

30870_dirs_2014-12-31_f0b812d5-d7b8-47f1-9700-f0e6ff4595b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-12-30

Reporting Person: Malik Fady Ibraham (SVP Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-30 Common Stock S 15905 $6.73 Disposed 9086 Direct
2014-12-30 Common Stock S 1329 $6.74 Disposed 7757 Direct
2014-12-30 Common Stock S 611 $6.75 Disposed 7146 Direct
2014-12-30 Common Stock S 3285 $6.7501 Disposed 3861 Direct
2014-12-30 Common Stock S 500 $6.76 Disposed 3361 Direct